February Update: Pharma and Health
Preparations for a no-deal Brexit and the stockpiling of medicines dominated the discussion over Summer Recess. Find out what's happening in September.
Pharmaceuticals
September Update: Pharma and Health
Preparations for a no-deal Brexit and the stockpiling of medicines dominated the discussion over Summer Recess. Find out what's happening in September.
July Update: Pharma and Health
Parliament enters its summer recess from 24th July. Find out what's on the agenda for Health and Social Care.
June Update: Pharma and Health
Health is at the heart of the political landscape this month. Read Consultant Daniel Shaw-Stewart's June forecast.
May Update: Pharma and Health
May sees the inaugural meeting of the new UK Life Sciences Council in Downing Street. Find out what else is happening this month with Monitoring Consultant Daniel Shaw-Stewart.
April Update: Pharma and Health
Industry discussions are set to dominate April for the Health sector, as stakeholders meet to discuss key topics. Read more from Monitoring Consultant Daniel Shaw-Stewart.
March Update: Health and Pharmaceuticals
Some key legislative proposals on Health from the Government remain on hold this month but a double Parliamentary session means progress on high-profile Private Members' Bills. Read more from Monitoring Consultant Daniel Shaw-Stewart.
February Update: Health and Pharmaceuticals
From major health and care reviews to the implications of Brexit for the NHS, February looks set to be an eventful month. Read more from Monitoring Consultant Daniel Shaw-Stewart.
January Update: Health and Pharmaceuticals
A winter A&E crisis rears its head this month, in tandem with speculation about a possible change at the top of the Department of Health. Read more from Monitoring Consultant Daniel Shaw-Stewart.
December Update: Health and Pharmaceuticals
Life sciences investment is high up the agenda this month against a Brexit backdrop, while a new Green Paper on CAMHs is provoking important funding conversations. Read more from Monitoring Consultant Daniel Shaw-Stewart.
